JP2023538369A5 - - Google Patents

Info

Publication number
JP2023538369A5
JP2023538369A5 JP2023511960A JP2023511960A JP2023538369A5 JP 2023538369 A5 JP2023538369 A5 JP 2023538369A5 JP 2023511960 A JP2023511960 A JP 2023511960A JP 2023511960 A JP2023511960 A JP 2023511960A JP 2023538369 A5 JP2023538369 A5 JP 2023538369A5
Authority
JP
Japan
Prior art keywords
antibody
antigen
sequence
binding fragment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023511960A
Other languages
English (en)
Japanese (ja)
Other versions
JP7906719B2 (ja
JP2023538369A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/112771 external-priority patent/WO2022037531A1/zh
Publication of JP2023538369A publication Critical patent/JP2023538369A/ja
Publication of JP2023538369A5 publication Critical patent/JP2023538369A5/ja
Application granted granted Critical
Publication of JP7906719B2 publication Critical patent/JP7906719B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023511960A 2020-08-17 2021-08-16 抗cd73抗体とその使用 Active JP7906719B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202010828886.4 2020-08-17
CN202010828886 2020-08-17
CN202011152518.9 2020-10-23
CN202011152518 2020-10-23
PCT/CN2021/112771 WO2022037531A1 (zh) 2020-08-17 2021-08-16 抗cd73的抗体及其用途

Publications (3)

Publication Number Publication Date
JP2023538369A JP2023538369A (ja) 2023-09-07
JP2023538369A5 true JP2023538369A5 (cg-RX-API-DMAC7.html) 2024-08-26
JP7906719B2 JP7906719B2 (ja) 2026-08-18

Family

ID=

Similar Documents

Publication Publication Date Title
US10125188B2 (en) Human antibodies to respiratory syncytial virus F protein and methods of use thereof
KR101671452B1 (ko) 항rsv g 단백질 항체
US9861696B2 (en) Monoclonal antibodies for Ebola and Marburg viruses
JP2023549067A5 (cg-RX-API-DMAC7.html)
CN115666649B (zh) 一种新型冠状病毒抗体的药物组合物及其用途
JP2017518958A (ja) 免疫原性グリコペプチドに対する抗体、それを含む組成物、及びそれらの使用
JP2020529835A5 (cg-RX-API-DMAC7.html)
JP2015518369A (ja) B型インフルエンザウイルスに結合して中和することができるヒト結合分子およびその使用
JP2011501656A5 (cg-RX-API-DMAC7.html)
EP3360896B1 (en) Antibody to hepatitis b surface antigen and use thereof
JP2024531151A5 (cg-RX-API-DMAC7.html)
RU2765878C2 (ru) Антитела для лечения инфекции гепатитом в и связанных с ней заболеваний
US20180237502A1 (en) Pan-ebola and pan-filovirus protective epitopes, antibodies, and antibody cocktails
JP2024527607A5 (cg-RX-API-DMAC7.html)
WO2016078761A1 (en) Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof
US20140161833A1 (en) Novel neutralizing immunogen (nimiv) of rhinovirus and its uses for vaccine applications
WO2015028888A2 (en) Pharmaceutical compositions to treat viral infection
CN102216330B (zh) 用于病毒所致的疾病的抗体药物组合物
JP2023511956A5 (cg-RX-API-DMAC7.html)
CN113549146B (zh) 针对柯萨奇病毒b1型的单克隆抗体及其用途
CN114773461B (zh) 乙型脑炎病毒抗体1d11及其应用
US20220340658A1 (en) NEUTRALIZING ANTI-SARS-CoV-2 ANTIBODIES AND USE THEREOF
CN112996540A (zh) 一种c-Met ADC在制备治疗c-Met激酶抑制剂耐药的疾病的药物中的用途
JP2022553703A5 (cg-RX-API-DMAC7.html)
WO2022023292A9 (en) Corona virus spike protein-targeting antibodies and use thereof